查看完整行情页>>

|

货币单位:美元(USD)

安进公司

Amgen, Inc. (amgn)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Matthew C. Busch Presently, Matthew C. Busch is Chief Accounting Officer & Vice President-Finance at Amgen, Inc. Mr. Busch received an undergraduate degree and a graduate degree from Brigham Young University.
David M. Reese David M. Reese is a businessperson who founded Translational Oncology Research International, Inc. and who has been at the helm of 7 different companies. He is on the board of CEO Roundtable on Cancer, Inc. and Research!America and Chief Technology Officer & Executive VP at Amgen, Inc. In the past David M. Reese held the position of Director-Clinical Research at Breast Cancer International Research Group Ltd. and Director-Clinical Research at Translational Research In Oncology. Dr. Reese received an undergraduate degree from Harvard College and an undergraduate degree from The University of Cincinnati College of Medicine.
Jean-Charles Soria Founder of Gritstone bio, Inc., Jean-Charles Soria is SVP-Research and Development at Amgen, Inc. Dr. Soria is also Director-General at Institut Gustave Roussy EURL and Professor at Université Paris-Saclay. In the past he occupied the position of Senior VP-Oncology Research & Development at AstraZeneca US, Senior Vice President of AstraZeneca PLC and Senior Vice President of MedImmune LLC (a subsidiary of AstraZeneca PLC) and Associate Professor at The University of Texas M.D. Anderson Cancer Center.
Esteban Santos Esteban Santos is Executive Vice President-Operations for Amgen, Inc. In the past Mr. Santos held the position of General Manager-Cordis Site at Johnson & Johnson. He received an undergraduate degree from the University of Puerto Rico and a graduate degree from Rensselaer Polytechnic Institute.
Darryl Sleep Presently, Darryl Sleep holds the position of Chief Medical Officer & Senior VP-Global Medical at Amgen, Inc. He previously occupied the position of Head-Urology at Johannesburg Academic Hospital, Academic Head-Urology Department at Kalafong Academic Hospital, Senior VP, Head-US Medical Office & Affairs at Takeda Pharmaceuticals U.S.A., Inc. and Professor at the University of Pretoria. Darryl Sleep received an undergraduate degree from the University of the Witwatersrand.
Mike Zahigian Presently, Mike Zahigian is Chief Information Officer & Senior Vice President of Amgen, Inc. In his past career Mr. Zahigian occupied the position of Vice President-Technology at Sourcemine, Inc. Mr. Zahigian received an undergraduate degree from the University of Southern California and an MBA from Graziadio School of Business & Management.
Peter H. Griffith Currently, Peter H. Griffith is Chief Financial Officer & Executive Vice President of Amgen, Inc. Mr. Griffith is also on the board of Alantos Pharmaceuticals Holding, Inc. and BioVex Group, Inc. Mr. Griffith previously occupied the position of President at Sherwood Canyon Group LLC, Global Vice Chairman-Corporate Development at Ernst & Young Global Ltd. and Managing Director & Head-Investment Banking at Wedbush Securities, Inc. Peter H. Griffith received an undergraduate degree from USC Marshall School of Business.
Nancy A. Grygiel Presently, Nancy A. Grygiel occupies the position of Chief Compliance Officer at Amgen, Inc. Ms. Grygiel is also on the board of Amgen Foundation, Inc. and United Way of Ventura County. Ms. Grygiel previously held the position of VP-Compliance, Corporate & International at Allergan, Inc. She received a graduate degree from Georgetown University Law Center and a graduate degree from Universidad de Buenos Aires.
Linda H. Louie Linda H. Louie is Vice President-Finance of Amgen, Inc. Ms. Louie received an MBA from The Fuqua School of Business.
Paul Burton Currently, Paul Burton occupies the position of Chief Medical Officer at Amgen, Inc. and Chief Global Medical Affairs Officer at Janssen Pharmaceuticals, Inc. Dr. Burton is also Member of Royal College of Surgeons. In the past he occupied the position of Chief Global Medical Affairs Officer at Johnson & Johnson and Vice President for Janssen Research & Development LLC (a subsidiary of Johnson & Johnson) and Chief Medical Officer for Moderna, Inc. He received a doctorate from the University of London and a doctorate from Imperial College London.
James E. Bradner James E. Bradner is an American entrepreneur who founded 5 companies, which include: C4 Therapeutics, Inc., Syros Pharmaceuticals, Inc. and Acetylon Pharmaceuticals, Inc. Currently, he is Chief Scientific Officer for Amgen, Inc., Advisor at Longwood Fund Management LLC and Chairman at Novartis Institute for Functional Genomics, Inc. Dr. Bradner is also on the board of Foundation for the National Institutes of Health, Inc. and Associate Professor at Harvard Medical School. In his past career he occupied the position of Associate Director-Therapeutics Science Centre at The Broad Institute, Inc., President at Novartis Institutes for Biomedical Research, Inc., Member of American Chemical Society, Member of American Society of Hematology, Director at Acetylon Pharmaceuticals, Inc., Director at TetraLogic Research & Development Corp. and Director at Syros Pharmaceuticals, Inc. James E. Bradner received an undergraduate degree from Harvard University and a doctorate from Pritzker School of Medicine.
Derek Miller Presently, Derek Miller is Chief Human Resources Officer at Amgen, Inc. Mr. Miller is also Chief Financial Officer & Senior Vice President of Southeast Alabama Medical Center. Mr. Miller received an undergraduate degree from Grinnell College, an MBA from National University of Singapore and an MBA from Anderson School of Management.
Robert A. Bradway Presently, Robert A. Bradway occupies the position of Chairman, President & Chief Executive Officer at Amgen, Inc. He is also Member of American Heart Association, Inc. and on the board of 6 other companies. He previously was Managing Director at Morgan Stanley & Co. International Plc, Chief Financial Officer & Director at Alantos Pharmaceuticals Holding, Inc. and Principal at Morgan Stanley & Co. LLC. Robert A. Bradway received an undergraduate degree from Amherst College and an MBA from Harvard Business School.
Brian J. Druker Brian J. Druker founded Blueprint Medicines Corp. and MolecularMD Corp. He is on the board of Amgen, Inc., The Burroughs Wellcome Fund, Vincerx Pharma, Inc. and OHSU Knight Cancer Institute and Director & Associate Dean at Oregon Health & Science University. He received an undergraduate degree and a doctorate from the University of California San Diego.
Ellen Jamison Kullman Ellen Jamison Kullman is a businessperson who has been the head of 7 different companies and is Executive Chairman of Carbon, Inc., Co-Chairman at Paradigm For Parity LLC and Chief Executive Officer at DuPont Argentina SRL. Ms. Kullman is also Member-Board of Overseers at Tufts University, Member of National Academy of Engineering, Member of The Business Council and Member of The Committee of 200 and on the board of 7 other companies. She previously occupied the position of Member of US India CEO Forum, Chairman, President & Chief Executive Officer for EIDP, Inc., Chairman & Chief Executive Officer of Axalta Coating Systems LLC, President of DuPont Safety Resources, Vice President & General Manager at DuPont Titanium Technologies, Inc., Executive Vice President at DuPont Merck Pharmaceutical Co., Executive Vice President at DuPont Coatings & Color Technologies Group, Group Vice President at The DuPont Safety & Protection, Executive Vice President at DuPont Performance Materials, Executive Vice President at DuPont Electronic & Communication Technologies, Vice President & General Manager at DuPont Bio-Based Materials, Inc. and Director at US-China Business Council. Ellen Jamison Kullman received a graduate degree from Kellogg School of Management and an undergraduate degree from Tufts University.
Robert Sanders Williams Robert Sanders Williams is Vice President-Research & Innovation at The University of California, San Francisco, Professor at Duke University, Member of National Academy of Medicine (United States), Member of Association of American Physicians, Member of American Society for Clinical Investigation and Member of Western Association of Physicians and on the board of 6 other companies. In his past career he occupied the position of President for Association of University Cardiologists, Senior Vice Chancellor at Duke University Medical Center, Chief-Cardiology & Director-Ryburn Center at The University of Texas Southwestern Medical Center, Member-Governing Board at Duke-NUS Graduate Medical School Singapore and Vice Chancellor at Duke University School of Medicine. Dr. Williams received an undergraduate degree from Princeton University and a doctorate from Duke University.
Ronald D. Sugar Ronald D. Sugar is a businessperson who has been the head of 6 different companies and currently holds the position of Chairman at Uber Technologies, Inc., Advisory Board at Vance Street Management LLC, Advisor at Alpha Edison Management Co. LLC, Special Advisor at Artius Management LLC and Chairman of Pearl Harbor Memorial Fund. Dr. Sugar is also Member of National Academy of Engineering and Director-Board of Visitors at UCLA Anderson School of Management and on the board of 7 other companies. In his past career he occupied the position of Chairman & Chief Executive Officer of Northrop Grumman Corp. President, Chief Operating Officer & Director at Litton Industries, Inc. President & Chief Operating Officer for TRW Aerospace and Chief Financial Officer for Northrop Grumman Space & Mission Systems Corp. (which are all subsidiaries of Northrop Grumman Corp.), Chairman at Aerospace Industries Association, Chief Operating & Financial Officer of TRW, Inc. and Senior Advisor at Ares Management LLC. He received a doctorate, a graduate degree and an undergraduate degree from the University of California, Los Angeles.
Amy E. Miles Amy E. Miles is a businessperson who has been the head of 5 different companies. Ms. Miles holds the position of Independent Non-Executive Chairman for Norfolk Southern Corp. Ms. Miles is also on the board of 7 other companies. Ms. Miles previously occupied the position of Chairman & Chief Executive Officer at Regal Entertainment Group, Chief Executive Officer for Regal Cinemas, Inc., President & Director at United Artists Theatre Circuit, Inc., Senior Manager at PricewaterhouseCoopers LLP, Senior Manager at Deloitte & Touche LLP and Vice Chairman & Executive Director at National Association of Theatre Owners. She received an undergraduate degree from the University of Tennessee.
Greg C. Garland Greg C. Garland is a businessperson who has been at the helm of 8 different companies and currently occupies the position of Executive Chairman at Phillips 66, Chairman & Chief Executive Officer of Phillips 66 Co. and Chairman & Chief Executive Officer at Phillips 66 Partners GP LLC (both are subsidiaries of Phillips 66) and Co-Chairman for The Prium (United States). He is also Member-Engineering Advisory Council at Texas A&M University and Member-Visitors Board at The University of Texas M.D. Anderson Cancer Center and on the board of 6 other companies. Greg C. Garland previously occupied the position of President & Chief Executive Officer of Chevron Phillips Chemical Co. LLC, Senior VP-Exploration & Americas Production at ConocoPhillips and General Manager-Qatar & Middle East Region at Phillips Petroleum Co. (a subsidiary of ConocoPhillips) and Chairman & Chief Executive Officer at Phillips 66 Partners LP. Mr. Garland received an undergraduate degree from Texas A&M University.
Omar Syed Ishrak Founder of Compute Health Acquisition Corp., Omar Syed Ishrak is an American businessperson who has been the head of 12 different companies and presently occupies the position of Chairman of Biofourmis, Inc., Co-Chairman for Allurion Technologies, Inc. and Chairman & Chief Executive Officer at Medtronic Trading NL BV. Dr. Ishrak is also Director-Health Leadership Council at Save The Children Foundation and on the board of 8 other companies. In the past Dr. Ishrak held the position of Executive Chairman for Medtronic Plc Executive Chairman of Medtronic, Inc. and Executive Chairman for Medtronic Ltd. (both are subsidiaries of Medtronic Plc), President & Chief Executive Officer at Health Care Systems, Inc., Senior Vice President of General Electric Co. and President & Chief Executive Officer at GE Healthcare Clinical Systems (Wisconsin) (a subsidiary of General Electric Co.), Chairman at Compute Health Acquisition Corp., President & Chief Executive Officer for Clinical Systems, Inc., President & Chief Executive Officer of GE Healthcare, Inc. and General Manager of Ultrasound, Inc. Omar Syed Ishrak received an undergraduate degree and a doctorate from King's College London.
Wanda M. Austin Wanda M. Austin is a businessperson who founded Making Space, Inc. and who has been at the head of 5 different companies. She occupies the position of Chairman at Hampton Roads Chapter of The American Red Cross, Chief Executive Officer for Making Space, Inc., President at USC Norris Comprehensive Cancer Center and Member of National Academy of Engineering. She is also on the board of Amgen, Inc., Apple, Inc., Chevron Corp. and Horatio Alger Association of Distinguished Americans, Inc. and Member of International Academy of Astronautics. Wanda M. Austin previously occupied the position of Member of National Aeronautics & Space Administration, Principal at United States Defense Science Board, President, Chief Executive Officer & Trustee at The Aerospace Corp., President at the University of Southern California and Principal at The California Council on Science & Technology. Wanda M. Austin received an undergraduate degree from Franklin & Marshall College, a graduate degree from the University of Pittsburgh and a doctorate from the University of Southern California.
Michael V. Drake Michael V. Drake is on the board of Amgen, Inc. and Bank of the West (California) and President for the University of California. In his past career he was President & Director at The Ohio State University Wexner Medical Center, Chairman for Association of Academic Health Centers and Chancellor at the University of California, Irvine. He received a doctorate from The University of California, San Francisco and an undergraduate degree from Stanford University.
Tyler E. Jacks Founder of T2 Biosystems, Inc. and Dragonfly Therapeutics, Inc., Tyler E. Jacks currently is President & Director at Commonwealth Cancer Consortium, Inc. He is also on the board of Amgen, Inc. and Thermo Fisher Scientific, Inc. and Professor at Massachusetts Institute of Technology. He previously held the position of Director at David H. Koch Institute for Integrative Cancer Research and Chairman for National Cancer Institute. He received an undergraduate degree from Harvard University and a doctorate from The University of California, San Francisco.
Charles M. Holley Charles M. Holley is on the board of Amgen, Inc., Phillips 66 and Carrier Global Corp. and Member-Development Board at The University of Texas at Austin, Member of Financial Executives International, Member of McCombs Foundation, Inc., Member of Texas Society of Certified Public Accountants and Member of The Conference Board Council of Financial Executives. In the past Charles M. Holley occupied the position of Executive Vice President of Walmart, Inc. and Chief Financial Officer & Senior Vice President of Wal-Mart International (a subsidiary of Walmart, Inc.), Principal at Ernst & Young LLP and MD-European Memorex Consumer Product Division at Tandy Corp. He received an undergraduate degree from The University of Texas at Austin and an MBA from the University of Houston.